Protective Effect of the T1212C Macrophage Mannose Receptor Gene Polymorphism on Pulmonary Tuberculosis

Yani Triyani, Julia Hartati, Budiman Budiman, Ida Parwati, Bachti Alisjahbana


The interaction between the mannose receptor, which is encoded by the macrophage mannose receptor (MMR) gene, and the most virulent antigen (the mannose-capped lipoarabinomannan) cell wall of virulent strains of Mycobacterium tuberculosis trigger an innate and adaptive immune response. It also produces pro and anti-inflammatory cytokines, which play a role in the pathogenesis of tuberculosis (TB) infection. Therefore, MMR gene polymorphism is a risk factor associated with the prognosis for active pulmonary TB. This study aimed to determine the correlation between MMR gene polymorphism and active or latent pulmonary tuberculosis. In this phase, MMR gene polymorphism was analyzed using a case-control design consisting of 74 control group subjects (patients with latent TB) and 74 case groups (patients with active pulmonary TB). The subject’s MMR gene DNA sequencing examination. The study was conducted at the Teaching Hospital, Faculty of Medicine, Universitas Padjadjaran Bandung, from February 2014 to January 2015. The statistical analysis used chi-square and odds ratio. The study’s result has shown the MMR gene polymorphism factor that correlated to the incidence of active pulmonary TB was T1212C (OR=0.253; 95% CI=0.111−0.575; p=0.001). There was an MMR gene in one SNP in the control group (C1323T) only and five single nucleotide polymorphisms (SNPs) in both groups (C1303T, C1221, T1212C, G1186A, and G1195A). Therefore, it can be concluded that MMR gene polymorphism on the T1212C site correlated with the incidence of active pulmonary tuberculosis and was protective.


Active pulmonary TB; latent TB; MMR gene; single nucleotide polymorphisms; T1212C

Full Text:



Nkereuwem E, Kampmann B, Togun T. The need to prioritise childhood tuberculosis case detection. Lancet. 2021;397(10281):1248–9.

de Martino M, Lodi L, Galli L, Chiappini E. Immune response to Mycobacterium tuberculosis: a narrative review. Front Pediatr. 2019;7:350.

Lugo-Villarino G, Troegeler A, Balboa L, Lastrucci C, Duval C, Mercier I, et al. The C-Type Lectin receptor DC-SIGN has an anti-inflammatory role in human M(IL-4) macrophages in response to Mycobacterium tuberculosis. Front Immunol. 2018;9:1123.

Liu CH, Liu H, Ge B. Innate immunity in tuberculosis: host defense vs pathogen evasion. Cell Mol Immunol. 2017;14(12):963–75.

Banda JM, Essien UC, Ebu M, Isa BE, Yakubu BD, Joshua IA, et al. Prevalence of Mycobacterium tuberculosis among HIV-positive patients attending COCIN Rehabilitation Center in Mangu, Jos, Plateau State, Nigeria. Arch Microbiol Immunol. 2021;5(2):207–213.

Rajaram MVS, Arnett E, Azad AK, Guirado E, Ni B, Gerberick AD, et al. M. tuberculosis-initiated human mannose receptor signaling regulates macrophage recognition and vesicle trafficking by FcRγ-chain, Grb2 and SHP-1. Cell Rep. 2017;21(1):126–40.

Jagatia H, Tsolaki AG. The role of complement system and the immune response to tuberculosis infection. Medicina (Kaunas). 2021;57(2):84.

Suzuki Y, Shirai M, Asada K, Yasui H, Karayama M, Hozumi H, et al. Macrophage mannose receptor, CD206, predict prognosis in patients with pulmonary tuberculosis. Sci Rep. 2018;8(113129.

Qidwai T, Jamal F, Khan MY. DNA sequence variation and regulation of genes involved in pathogenesis of pulmonary tuberculosis. Scand J Immunol. 2012;75(6):568–87.

Azad AK, Sadee W, Schlesinger LS. Innate immune gene polymorphisms in tuberculosis. Infect Immun. 2012;80(10):3343–59.

Zhang X, Jiang F, Wei L, Li F, Liu J, Wang C, et al. Polymorphic allele of human MRC1 confer protection against tuberculosis in a Chinese population. Int J Biol Sci. 2012;8(3):375–82.

Zhang X, Li X, Zhang W, Wei L, Jiang T, Chen Z, et al. The novel human MRC1 gene polymorphisms are associated with susceptibility to pulmonary tuberculosis in Chinese Uygur and Kazak populations. Mol Biol Rep. 2013;40(8):5073–83.

Sayers EW, Bolton EE, Brister JR, Canese K, Chan J, Comeau DC, et al. Database resources of the National Center for Biotechnology Information. Nucleic Acids Res. 2022;50(D1):D20–6.

Choi H, Yoo JE, Han K, Choi W, Rhee SY, Lee H, et al. Body mass index, diabetes, and risk of tuberculosis: a retrospective cohort study. Front Nutr. 2021;8:739766.

Cho SH, Lee H, Kwon H, Shin DW, Joh HK, Han K, et al. Association of underweight status with the risk of tuberculosis: a nationwide population-based cohort study. Sci Rep. 2022;12(1):16207.

Pande T, Huddart S, Xavier W, Kulavalli S, Chen T, Pai M, et al. Prevalence of diabetes mellitus amongst hospitalized tuberculosis patients at an Indian tertiary care center: a descriptive analysis. PLoS One. 2018;13(7):e0200838.

Jurcev-Savicevic A, Mulic R, Ban B, Kozul K, Bacun-Ivcek L, Valic J, et al. Risk factors for pulmonary tuberculosis in Croatia: a matched case–control study. BMC Public Health. 2013;13:991.

Ilavská S, Horváthová M, Szabová M, Nemessányi T, Jahnová E, Tulinská J, et al. Association between the human immune response and body mass index. Hum Immunol. 2012;73(5):480–5.

Alter A, de Léséleuc L, Van Thuc N, Thai VH, Huong NT, Ba NN, et al. Genetic and functional analysis of common MRC1 exon 7 polymorphisms in leprosy susceptibility. Hum Genet. 2010;127(3):337–48.

Hattori T, Konno S, Takahashi A, Isada A, Shimizu K, Shimizu K, et al. Genetic variants in mannose receptor gene (MRC1) confer susceptibility to increased risk of sarcoidosis. BMC Med Genet. 2010;11:151.

Wright PB, McDonald E, Bravo-Blas A, Baer HM, Heawood A, Bain CC, et al. The mannose receptor (CD206) identifies a population of colonic macrophages in health and inflammatory bowel disease. Sci Rep. 2021;11(1):19616.

Azad AK, Rajaram MV, Schlesinger LS. Exploitation of the macrophage mannose receptor (CD206) in infectious disease diagnostics and therapeutics. J Cytol Mol Biol. 2014;1(1):1000003.

Konečný P, Ehrlich R, Gulumian M, Jacobs M. Immunity to the dual threat of silica exposure and Mycobacterium tuberculosis. Front Immunol. 2019;9:3069.

Tanaka S, Ohgidani M, Hata N, Inamine S, Sagata N, Shirouzu N, et al. CD206 expression in induced microglia-like cells from peripheral blood as a surrogate biomarker for the specific immune microenvironment of neurosurgical diseases including glioma. Front Immunol. 2021;12:670131.

Shen YW, Zhang YM, Huang ZG, Wang GC, Peng QL. Increased levels of soluble CD206 associated with rapidly progressive interstitial lung disease in patients with dermatomyositis. Mediators Inflamm. 2020;2020:7948095.

MacLean E, Bigio J, Singh U, Klinton JS, Pai M. Global tuberculosis awards must do better with equity, diversity, and inclusion. Lancet. 2021;397(10270):192–3.

Harishankar M, Selvaraj P, Bethunaickan R. Influence of genetic polymorphism towards pulmonary tuberculosis susceptibility. Front Med (Lausanne). 2018;5:213.

Ghanavi J, Farnia P, Farnia P, Velayati AA. Human genetic background in susceptibility to tuberculosis. Int J Mycobacteriol. 2020;9(3):239–47.

Seshadri C, Thuong NT, Mai NT, Bang ND, Chau TT, Lewinsohn DM, et al. A polymorphism in human MR1 is associated with mRNA expression and susceptibility to tuberculosis. Genes Immun. 2017;18(1):8–14.


pISSN 2301-9123 | eISSN 2460-5441

Visitor since 19 October 2016: 

View My Stats

Free counters!

Global Medical and Health Communication is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.